"Designing Growth Strategies is in our DNA"

Metformin Hydrochloride Tablets Market Size, Share & Industry Analysis, By Type (Metformin Hydrochloride – Immediate-release, Metformin Hydrochloride – Extended-release), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Others) and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI103104 | Status : Ongoing

 

KEY MARKET INSIGHTS

Metformin is an oral medicine that is used with proper diet and exercise programe to control high blood sugar levels in patients with type-2 diabetes. Metformin works by helping to restore the body’s naturally produced insulin. It also decreases the amount of sugar which is produced by the liver. Although metformin is an important medication for type-2 diabetes, it is accompanied with certain side-effects such as lactic acidosis, unusual muscle pain, slow or irregular heart beat, difficulty in breathing, stomach pain, and vomiting. On the other hand, growing prevalence of type-2 diabetes, rising geriatric population, numerous product launches by the key market players, and growing awareness among the patient population are the factors that are fueling the metformin hydrochloride tablets market.  For instance, in May 2017, Teva Pharmaceutical Industries Ltd. announced the launch of generic Glumetza (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the U.S.


The metformin hydrochloride tablets market is anticipated to register a significant growth during the forecast period due to factors such as growing geriatric population, increasing patient pool of type-2 diabetes, and numerous product launches by key players. However, various side-effects associated with the drug is one of the major factors likely to hamper the growth of metformin hydrochloride tablets market.


Key Market Driver -

Rising prevalence of diabetes, growing geriatric population

Key Market Restraint -

Side effects associated with the drug


Market Segmentation:


Globally, the metformin hydrochloride tablets market can be segmented on the basis of the type, patient, distribution channel, and region. Based on the type, the market can be segmented into metformin hydrochloride – immediate-release and metformin hydrochloride – extended-release. Based on the distribution channel, the market can be segmented into hospitals pharmacies, retail pharmacies, and others. Geographically, the metformin hydrochloride tablets market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the metformin hydrochloride tablets market are Bristol-Myers Squibb Company, Glenmark Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., LUPIN., Shandong Keyuan Pharmaceutical Co., Ltd., Merck & Co., Inc., Vistin Pharma AS, and other prominent players.


Key Insights:



  • Key Industry Trends

  • New Product Launches

  • Key Industry Developments Mergers, Acquisitions, And Collaborations


Regional Analysis:


Geographically, the metformin hydrochloride tablets market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the metformin hydrochloride tablets market throughout the forecast period. Growth witnessed in this region is mainly driven by the increasing demand for the drug due to the growing number of patients with type-2 diabetes and rising geriatric population. For instance, according to American Diabetes Association, in 2015, the annual incidence of diagnosed diabetes was estimated as 18,200 with type 1 diabetes, 5,800 with type 2 diabetes. Europe is anticipated to hold second largest market share in metformin hydrochloride tablets market. Increasing geriatric population and various product launches by the key market players is likely to spur the market growth in this region. On the flip side, Asia Pacific is projected to register the highest CAGR. Rising geriatric population in countries such as China and India, growing incidence of type-2 diabetes is likely to boost the market growth of this region.


To gain extensive insights into the market, Request for Customization


The market in Latin America and the Middle East & Africa are in nascent stage. However, growing patient awareness regarding the disease and the drug in these regions are likely to help witness a considerable growth in the market in the upcoming years.


Segmentation






















 ATTRIBUTE


  DETAILS

By Type




  • Metformin Hydrochloride – Immediate-release

  • Metformin Hydrochloride – Extended-release



By Distribution Channel




  • Hospitals Pharmacies

  • Retail Pharmacies

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Metformin Hydrochloride Tablets Market Industry Developments



  • In November 2019, Glenmark Pharmaceuticals Inc., received USFDA approval for metformin hydrochloride extended-release tablet USP, 500 mg and 1000 mg, used in the management of Type-2 diabetes.

  • In May 2017, Teva Pharmaceutical Industries Ltd. announced the launch of generic Glumetza (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the U.S.

  • In February 2016, Lupin announced that its US subsidiary, Lupin Pharmaceutical Inc. launched metformin hydrochloride extended-release tablets, 500 mg and 1000 mg to market a generic equivalent of Santarus Inc.'s Glumetza HCl ER Tablets, 500 mg and 1000 mg.


Metformin Hydrochloride Tablets Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Sedana-Cyan-Black-Tag
SUANFARMA
lpsos
DUPONT
Abbott

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X